Five Pine Wealth Management Summit Therapeutics Inc. Transaction History
Five Pine Wealth Management
- $123 Billion
- Q1 2025
A detailed history of Five Pine Wealth Management transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Five Pine Wealth Management holds 13,588 shares of SMMT stock, worth $334,808. This represents 0.21% of its overall portfolio holdings.
Number of Shares
13,588
Previous 29,746
54.32%
Holding current value
$334,808
Previous $531 Million
50.62%
% of portfolio
0.21%
Previous 0.45%
Shares
2 transactions
Others Institutions Holding SMMT
# of Institutions
235Shares Held
83.3MCall Options Held
1.66MPut Options Held
2.56M-
Baker Bros. Advisors LP New York, NY24.4MShares$602 Million4.83% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$288 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$195 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.56MShares$162 Million0.01% of portfolio
-
State Street Corp Boston, MA5.6MShares$138 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $4.96B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...